Latest news
FDA‑approved TED drug and new notes reshape Viridian Therapeutics (NASDAQ: VRDN) - Stock TitanStock Titan · Thu, 06 Aug 2026 11:32:22 GMTViridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results - Business WireBusiness Wire · Thu, 06 Aug 2026 11:01:00 GMTHow Positive Elegrobart REVEAL-1 Phase III Data Could Impact Viridian Therapeutics (VRDN) Investors - simplywall.stsimplywall.st · Thu, 30 Jul 2026 07:00:00 GMT